comparemela.com

Latest Breaking News On - Institute of biomedicine seville - Page 2 : comparemela.com

Evgen Pharma PLC signs option to review sulforaphane analogues developed by Spanish research institutions

Evgen Pharma PLC (AIM:EVG) has signed an exclusive option to license novel sulforaphane analogues that may have the potential to be developed into products.

Researchers develop systems to detect an atypical fungus responsible for severe pneumonia

Researchers develop systems to detect an atypical fungus responsible for severe pneumonia The group led by Dr. Enrique J. Calderón - Clinical Epidemiology and Vascular Risk at the Institute of Biomedicine of Seville - IBiS/University Hospitals Virgen del Rocío and Macarena/CSIC/University of Seville, also a member of CIBERESP, participated in a project with researchers from CIBER-BBN, in which they developed systems to detect Pneumocystis jirovecii, an atypical fungus responsible for very severe pneumonia in immunosuppressed patients. The results have been published in the journals Nanomaterials and Journal of Fungi, and are the fruit of collaboration with the CIBER-BBN groups led by Dr. Laura Lechuga, Dr. Ramon Eritja and Dr. Ramón Martínez Máñez.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.